CClinicalTrials.gg
CompletedNCT04463355Updated Jul 9, 2020

Video Discharge Instructions for Pediatric Gastroenteritis in an Emergency Department

An interventional study of Video discharge instructions in Acute Gastroenteritis, sponsored by Hospital General Universitario Gregorio Marañon. Completed at 1 site in Spain. Open to participants aged 1 Month to 16 Years. Per ClinicalTrials.gov, last updated 2020-07-09.

Sponsored by Hospital General Universitario Gregorio Marañon · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jun 2019, registered Jun 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
139
Allocation
Randomized
Ages
1 Month to 16 Years
Sex
All
01

Study summary

Video discharge instructions (VDI) have been suggested as a useful strategy to improve discharge instructions in pediatric emergency units. The goal of this study is to evaluate if the addition of VDI to usual verbal information improved the comprehension of information provided to caregivers of patients who consult for acute gastroenteritis (AGE). An open-label, parallel, randomized trial was designed, enrolling patients who consult for AGE. First, caregivers answer a written test concerning AGE characteristics and management. They are randomly allocated to a control group, which receives verbal discharge instructions, or to an intervention group, which additionally receives video discharge instructions. After discharge, caregivers are contacted by telephone and answer the same test. Main outcome measure is difference between test scores in the first and the second tests, secondary endpoints are how many caregivers score 5/5 on the second test, as well as rate of return visits and caregivers satisfaction with the information received.

Read the detailed description

Video discharge instructions (VDI) have been suggested as a useful strategy to improve discharge instructions in pediatric emergency units. This study is designed to evaluate if the addition of VDI to usual verbal information improves the comprehension of the information provided to caregivers of patients who consult in pediatric emergency department for acute gastroenteritis (AGE). Secondary objectives are evaluating if video instructions improve satisfaction with the information received and decrease return visits.

The study is an open-label, parallel, randomized trial which takes place between June 2019 and June 2020 in the pediatric emergency department of a third-level Spanish hospital which receives 58000 emergencies annually. Up to 3 eligible patients are enrolled every shift when one of the main investigators is present. Simple, 1:1 randomization is performed using R software. Patients are randomly assigned to a group by opening sequentially numbered paper envelopes which contain the group in which the patient will be allocated, ensuring thus allocation concealment. Written informed consent is provided before trial enrollment.

Interventions

The trial is developed in three steps: an initial written test, an information phase and a second follow-up test after discharge. After enrollment, all patients fill-in a written test before discharge, which consists of 5 questions about AGE, 1 point per correct answer. Enrolled subjects are randomly assigned to the control or intervention group. In the first group of subjects (control group) caregivers receive, after completing the test and prior to discharge, the usual verbal information and recommendations about AGE following the guidelines of the Spanish Society of Pediatric Emergencies. In the second group (intervention group) patients are shown a short 2-minute video providing the same information about AGE, in addition to verbal instructions. In both groups, instructions are given by one of the main investigators in order to provide homogeneous and consistent information. Both sets of instructions explicitly include the information that had been previously asked in the test. All patients additionally receive a discharge report which includes instructions concerning aftercare treatment.

After discharge, all caregivers are contacted by telephone and asked the same 5 questions from the initial test. The questionnaire has to be completed by the same caregiver as in the previous test. This test also includes questions about subsequent visits to either emergency units or outpatient pediatric clinics and satisfaction with the information. The first telephonic contact is established 72 hours after discharge, and if unable to contact, repeated every 1-2 days up to a total of 5 days before excluding them and considering them as lost in follow-up.

Statistical Analysis The sample size was calculated to provide a statistical power of 80% at an alpha level of 5% to detect a two-tailed difference of 0.5 points between the two groups. It was calculated that with an estimated loss rate of 15% of patients between randomization and follow-up test, assuming a 1-point variance in test results based on previous studies, this statistical power would be reached by enrolling 75 patients in each group.

All randomized patients who complete both tests are included in the primary-end point analysis as part of the group in which they were randomized, following intention-to-treat principle. The differences in test points and satisfaction between groups are analyzed using Student's T-test, and the differences in proportions are analyzed using Chi-square test. Statistical significance is set at p\<0.05. Analysis are performed using Rv3.6.1 and SPSS.25 statistical softwares.

02

Conditions studied

  • Acute Gastroenteritis

Keywords

  • discharge instructions
  • video
  • acute gastroenteritis
  • pediatric emergency department
03

In context

Gastroenteritis

243 studies on the registry are indexed under Gastroenteritis; 15 are open to participants now.

This study's enrollment of 139 is above the median of 126 across 160 interventional studies indexed under Gastroenteritis.

Browse Gastroenteritis studies →

Lead sponsor

Hospital General Universitario Gregorio Marañon is the lead sponsor of 59 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who met ESPGHAN criteria for AGE: decreased stool consistency and/or increased evacuation frequency during a period \<7 days, associated or not to fever or vomiting.
  • Patients accompanied by a usual caregiver.

Exclusion criteria

Exclusion Criteria:

  • Patients with severe dehydration
  • Patients with chronic comorbidities needing special instructions (i.e. neurologic, respiratory or cardiologic)
  • Patients whose caregivers were not able to communicate in Spanish
  • Patients who were admitted for hospitalization.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
139 participants (actual)

Study arms

  • No intervention
    Control group: usual verbal instructions

    In this group, caregivers receive, after completing the test and prior to discharge, the usual verbal information and recommendations about AGE following the guidelines of the Spanish Society of Pediatric Emergencies. The instructions are always given by one of the main investigators to provide homogeneity in the information

  • Experimental
    Intervention group: video discharge instructions

    Additionally to the verbal information, patients are shown a short 2-minute video providing the same information about AGE that would be given by verbal information.

    Behavioral: Video discharge instructions

Interventions

  • BehavioralVideo discharge instructions

    Short video (2 minutes) including information about clinical features, management and follow up of pediatric patients with acute gastroenteritis

06

What researchers measure

Primary outcomes

  1. Change in test score

    We calculated the difference between the score obtained in the initial test and the score obteined in the follow-up test and compared between groups. Scores are based on a 5-question test, minimum score is 0 points and maximum score (best score) is 5 points

    Time frame: From 3 days to 10 days after first emergency care visit

Secondary outcomes

  1. Number of caregivers getting a total score of 5 points

    We measured how many caregivers got a 5-score (perfect) in the follow up test after interventions, and compared between groups

    Time frame: From 3 days to 10 days after first emergency care visit

  2. Rate of return visits

    We asked caregivers whether they had returned to emergency care or to pediatric outpatient clinics for the same problem after the first visit.

    Time frame: 72 hours from from the first emergency care visit

  3. Satisfaction score with the information received

    We asked caregivers to give a score between 1 and 10 (1 very unsatisfied, 10 very satisfied) regarding how useful they felt that the information given to them had been.

    Time frame: From 3 days to 10 days after first emergency care visit

07

Study locations

1 site
  • Hospital General Universitario Gregorio Marañón
    Madrid, 28009, Spain
08

References and documents

Study documents

  • Informed consent form · Mar 18, 2019
  • Protocol and statistical analysis plan · Mar 18, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — All collected IPD are available under request.

Supporting information: Study protocol, Sap, Icf, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04463355
Lead sponsor
Hospital General Universitario Gregorio Marañon
Responsible party
Gonzalo Solis Garcia (Dr. Gonzalo Solís García, Principal Investigator, Hospital General Universitario Gregorio Marañon) — Principal investigator
First posted
Jul 9, 2020
Start date
Jun 1, 2019
Primary completion
Mar 31, 2020
Completion
Jun 1, 2020
Last update
Jul 9, 2020

Study contacts

Gonzalo Solís, M.D.
principal investigator · Hospital General Universitario Gregorio Marañón

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion